Engineering small-molecule analogues of altiratinib via CREB-regulated transcription co-activator 3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases.
Jeong Hyeon LeeHongchan AnHyeJi KwonSu-Jeong LeeYoung Hye ParkJi Sun HwangMin Young KimHayoung HwangJeong Yoon KimSeung Jin LeeSung Eun ChangYoungsup SongPublished in: Clinical and translational medicine (2024)